gunu11's blog

Report Overview:

The Global Structural Biology and Molecular Modeling Market achieved a valuation of $7.02 Billion in 2022 and is anticipated to exceed $24.65 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 17% during the forecast period from 2024 to 2032.

Key Market Players:

Dassault Systèmes (France) , Agile Molecule , Acellera Ltd. (UK), ThermoFisher Scientific (US), Agilent Technologies Inc. (US)

Report Overview:

The Global Non Invasive Fat Reduction Market achieved a valuation of $675.11 Million in 2022 and is anticipated to exceed $2306.52 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 16.6% during the forecast period from 2024 to 2032.

Key Market Players:

Cutera Inc (US), Hologic Inc (US), Candela Corporation (US), Bausch Health Companies (Canada), Alma Lasers (Israel)

Report Overview:

The Global Obesity Treatment Market achieved a valuation of $11.63 Billion in 2022 and is anticipated to exceed $38.95 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 16.3% during the forecast period from 2024 to 2032.

Key Market Players:

VIVUS Inc. (US), Arena Pharmaceuticals Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novo Nordisk A/S (Denmark), Allergan Plc (US), Medtronic (US), Ethicon (a subsidiary of Johnson & Johnson) (US), Cousin Biotech (France), EnteroMedics Inc. (US), and USGI Medical Inc. (US).

Report Overview:

The Global Consumer Genomics Market achieved a valuation of $2.40 Billion in 2022 and is anticipated to exceed $10.25 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 19.9% during the forecast period from 2024 to 2032.

Key Market Players:

23andMe, Inc., Ancestry, Mapmygenome, Gene By Gene, Ltd. (FamilyTree DNA), Color Genomics, Inc., Futura Genetics, Positive Biosciences, Ltd., Helix OpCo LLC, Pathway Genomics, and MyHeritage Ltd.

Report Overview:

The Global Membrane Chromatography Market achieved a valuation of $231.15 Million in 2022 and is anticipated to exceed $707.08 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 15% during the forecast period from 2024 to 2032.

Key Market Players:

3M (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany)

Report Overview:

The Global Prostate Specific Antigen Testing Market achieved a valuation of $3.33 Billion in 2022 and is anticipated to exceed $7.74 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 11.1% during the forecast period from 2024 to 2032.

Key Market Players:

MDx Health (US), Myriad Genetics Inc (US)., Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), OPKO Health Inc. (US), and Genomic Health (US).

Report Overview:

The Global Digital Therapeutics Market achieved a valuation of $3.16 Billion in 2022 and is anticipated to exceed $14.52 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 27.9% during the forecast period from 2024 to 2032.

Key Market Players:

Report Overview:

The Global Synthetic Biology Market achieved a valuation of $12.70 Billion in 2022 and is anticipated to exceed $85.97 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 27% during the forecast period from 2024 to 2032.

Key Market Players:

Report Overview:

The Global Optogenetics Market achieved a valuation of $31.29 Billion in 2022 and is anticipated to exceed $101.90 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 15.9% during the forecast period from 2024 to 2032.

Key Market Players:

Scientifica (UK), Laserglow Technologies (Canada), Coherent Inc. (US), Cobolt Inc. (US), Thorlabs Inc. (US)

Report Overview:

The Global Gene Synthesis Market achieved a valuation of $2.35 Billion in 2022 and is anticipated to exceed $8.58 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 17.6% during the forecast period from 2024 to 2032.

Key Market Players:

Atum, ATDBio Ltd., Bioneer Corporation, Eurofins Scientific, Eurogentec, GenScript Biotech Corporation, Genewiz, Integrated DNA Technologies, Inc., OriGene Technologies, Inc., and Thermo Fisher Scientific, Inc.